ClinConnect ClinConnect Logo
Search / Trial NCT00734123

Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.

Launched by HOSPITAL ARNAU DE VILANOVA · Aug 13, 2008

Trial Information

Current as of June 05, 2025

Unknown status

Keywords

Atherosclerosis Cardiovascular Prevention Carotid Intima Media Thickness Ankle Brachial Index

ClinConnect Summary

We will perform non-invasive techniques (carotid Intima-Media Thickness, CAC score and ankle-brachial index) to individuals at intermediate cardiovascular risk.With these results, we will classify participants in: no atherosclerosis, mild, moderate and severe atherosclerosis, and therapeutic targets will be set according to pre-defined algorithms. The end-point will be the course of atherosclerosis measured by cIMT/CAC score (2 years) and the incidence of CVD at 5 years of follow-up.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • One or more of the following:
  • Familiar History of early-onset cardiovascular disease (male \< 55 or female \< 65).
  • Type 2 Diabetes mellitus or type 1 with microalbuminuria.
  • Essential High Blood Pressure.
  • Chronic Kidney Disease.
  • Primary hyperlipidemia.
  • The presence of two or more of the following:
  • Current smoker.
  • Physical inactivity.
  • High blood pressure (recently diagnosed).
  • Abdominal perimeter: \> 102 cm. males; \> 88 cm. females.
  • Total cholesterol \> 240 mg/dL.
  • HDL cholesterol ≤ 40 mg/dL males, ≤ 50 mg/dL females.
  • Exclusion Criteria:
  • Age \< 40 or \> 74 years old.
  • Previous Cardiovascular Event.

About Hospital Arnau De Vilanova

Hospital Arnau de Vilanova is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a collaborative approach to research, the hospital serves as a vital center for clinical studies across various therapeutic areas. Leveraging state-of-the-art facilities and a multidisciplinary team of experts, Hospital Arnau de Vilanova aims to contribute to the development of new treatments and therapies that enhance the quality of life for patients both locally and globally. Its focus on ethical standards and rigorous scientific methodology ensures the integrity and reliability of its research initiatives.

Locations

Lleida, Catalunya, Spain

Patients applied

0 patients applied

Trial Officials

Elvira Fernandez, MD,PhD

Principal Investigator

Hospital Arnau de Vilanova

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials